Fibrocell Science, Inc.

Formerly NASDAQ: FCSC
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 10-Q 2 pages Castle Creek Pharmaceutical Holdings, Inc. Castle Creek Pharmaceuticals, LLC Re: Agreement and Plan of Merger Ladies and Gentlemen
12/34/56
EX-10.2
from 8-K 17 pages Consent and Termination Agreement
12/34/56
EX-10.2
from DEFA14A 17 pages Consent and Termination Agreement
12/34/56
EX-10.1
from 8-K 18 pages Consent and Termination Agreement
12/34/56
EX-10.1
from DEFA14A 18 pages Consent and Termination Agreement
12/34/56
EX-10.2
from 8-K ~20 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K ~20 pages Employment Agreement
12/34/56
EX-10.5
from 10-Q 65 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Both (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Omissions Are Designated as [**] Fibrocell Science, Inc. and Castle Creek Pharmaceuticals, LLC Co-Development and License Agreement April 12, 2019 US-Docs\106669270.9
12/34/56
EX-10.4
from 8-K 4 pages Fibrocell Science, Inc. 2019 Equity Incentive Plan Nonqualified Stock Option Grant
12/34/56
EX-10.3
from 8-K 5 pages Fibrocell Science, Inc. 2019 Equity Incentive Plan Nonqualified Stock Option Grant
12/34/56
EX-10.2
from 8-K 5 pages Fibrocell Science, Inc. 2019 Equity Incentive Plan Incentive Stock Option Grant
12/34/56
EX-10.1
from 8-K 19 pages Fibrocell Science, Inc. 2019 Equity Incentive Plan Effective as of June 12, 2019
12/34/56
EX-10.1
from S-3 8 pages Material contract
12/34/56
EX-10.1
from 8-K 82 pages Material contract
12/34/56
EX-10.1
from 8-K 79 pages Material contract
12/34/56
EX-10.2
from 10-Q 33 pages Fibrocell Science, Inc. 2009 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 9 pages Material contract
12/34/56
EX-10.24
from 10-K 7 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 27 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 7 pages Separation Agreement and General Release
12/34/56